Cytori Therapeutics (CYTX) Amends and Extends Distribution Rights with GE Healthcare

September 16, 2010 8:45 AM EDT Send to a Friend
Get Alerts CYTX Hot Sheet
Trade CYTX Now!
Join SI Premium – FREE
Cytori Therapeutics, Inc. (Nasdaq: CYTX) announced that it has extended the term and modified the focus of its distribution agreement with GE Healthcare.

GE now has rights to sell select CYTX research in select European markets.

CYTX has co-exclusive sales rights into the research markets while retaining primary rights to sell into all clinical markets. The term of this agreement has been extended through the end of 2011.

Click here for details of the agreement.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Add Your Comment